The Netherlands on Thursday made a formal bid to become the new home of the European Medicines Agency which will likely have to relocate from London after Britain leaves the EU.
Apr 20, 2017
0
1
The U.S. Food and Drug Administration (FDA) reviews and approves new medicines in a shorter timeframe than its peer agency in Europe, the European Medicines Agency (EMA), says a Yale researcher. This finding, which comes ...
Apr 5, 2017
0
0
Last year, the Food and Drug Administration approved just 22 new therapeutic drugs, which is less than half the number approved in 2015. The cover story in Chemical & Engineering News (C&EN), the weekly newsmagazine of the ...
Feb 1, 2017
0
0
Tasked with giving new medicines the go-ahead across the EU, the European Medicines Agency is likely to have to relocate from its London base after Brexit—a prospect that is worrying its chief Guido Rasi.
Jan 26, 2017
2
1
From reading and hearing news accounts, the general public has a vague impression that some things are amiss with the pharmaceutical industry—one word: Epipens. But few might consider it an industry in a state of collapse.
Jan 12, 2017
0
49
According to a University of Colorado Cancer Center study published this week in the Journal of Clinical Oncology, a decade that saw the development of new therapies for non-small cell lung cancer resulted in little survival ...
Jan 5, 2017
0
6
Nearly 90 percent of patients at long-term care facilities don't take advantage of dental services, even when they are free, a recent study by University at Buffalo researchers has found.
Nov 22, 2016
0
1
World leaders are pushing to end the overuse of antibiotics and to encourage the development of new medicines, driven by concern that drug-resistant germs could lead to millions of deaths and undermine the global economy.
Sep 20, 2016
0
0
(HealthDay)—Eyebrows raised in Rio over the weekend when Olympic athletes like swimmer Michael Phelps started showing up with circular purple bruises on different parts of their bodies.
Aug 8, 2016
0
12
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline ...
Jun 1, 2016
0
53
